Vir Biotechnology (VIR) Cash from Financing Activities (2018 - 2025)
Vir Biotechnology's Cash from Financing Activities history spans 8 years, with the latest figure at $1.0 million for Q4 2025.
- On a quarterly basis, Cash from Financing Activities fell 17.74% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 million, a 13.74% decrease, with the full-year FY2025 number at $3.8 million, down 13.74% from a year prior.
- Cash from Financing Activities hit $1.0 million in Q4 2025 for Vir Biotechnology, up from $102000.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for VIR hit a ceiling of $87.5 million in Q1 2021 and a floor of $31000.0 in Q3 2024.
- Historically, Cash from Financing Activities has averaged $7.5 million across 5 years, with a median of $2.0 million in 2022.
- The widest YoY moves for Cash from Financing Activities: up 102844.71% in 2021, down 98.88% in 2021.
- Tracing VIR's Cash from Financing Activities over 5 years: stood at $5.7 million in 2021, then plummeted by 64.53% to $2.0 million in 2022, then dropped by 16.46% to $1.7 million in 2023, then decreased by 24.82% to $1.3 million in 2024, then fell by 17.74% to $1.0 million in 2025.
- Business Quant data shows Cash from Financing Activities for VIR at $1.0 million in Q4 2025, $102000.0 in Q3 2025, and $2.0 million in Q2 2025.